Summary
The product Anadrol, with an unknown manufacturer and batch number, was independently tested to verify its authenticity and potency. The sample was submitted by the manufacturer acepharmaadmin@protonmail.com and analyzed by Janoshik Analytical, a laboratory specializing in pharmaceutical quality control. The analysis measured the presence of Oxymetholone, with a purity level of 96%+, which is slightly below the expected 100% purity but still within an acceptable range.
The testing process began on 15 December 2023, with the sample received on 29 December 2023, and analysis completed on 3 January 2024. While the results indicate a slight underdosing, they still fall within an acceptable range for pharmaceutical products. This report serves as an educational resource to promote harm reduction and informed decision-making.
Detailed Report
Product Overview
- Manufacturer: ACE Pharmaceutical
- Product Name: Anadrol
- Active Ingredient: Oxymetholone
- Batch Number: Unknown
- Expiration Date: Not provided
- Delivery Method: Oral
Sample Acquisition and Testing
- Task Number: #37044
- Testing Ordered: 15 December 2023
- Sample Received: 29 December 2023
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: ACE Pharmaceuticals (Manufacturer)
- Analysis Paid For By: ACE Pharmaceuticals (Manufacturer)
Testing Results
- Specification: Expected purity level (100%)
- Measured Concentration: 96%+
- Accuracy: 96%+ (slightly below the expected purity level)
- Variance: -4%
Verification Details
- Verification URL: https://janoshik.com/tests/37044_T5JMJJEBS4XZ
Evaluation of Manufacturer-Submitted Testing
This analysis highlights the slight underdosing of the tested product, which may be due to natural variances in pharmaceutical production. While the results are within an acceptable range, it is important to note that manufacturer-submitted samples may not fully represent the consistency of the product across all batches. Independent third-party testing remains crucial to validate these findings comprehensively.
Conclusion
The analysis confirms that Anadrol is slightly underdosed, with a measured concentration of 96%+. This result reflects reasonable quality control for this batch but underscores the importance of additional testing to ensure consistent dosing across the product line. This report is provided to support educational and harm reduction efforts, helping consumers make informed choices regarding anabolic steroid products.
Disclaimer
This report is published for educational and harm reduction purposes. Manufacturer-submitted testing may involve inherent biases; however, it can still provide useful data when critically assessed alongside third-party or independent results. Readers are encouraged to use this information responsibly.
